New treatment option for Cesarean Section Complications
Official title Platelet Rich Plasma for Uterine Scar
ClinicalTrials.gov ID: NCT05224726
What this study is testing
- What it's testing
- When vessel wall injury occurs, platelets become activated, releasing more than 30 bioactive proteins, many of which have a fundamental role in hemostasis, inflammation and ultimate wound healing. Platelet-rich plasma (PRP), a modification of fibrin glue made from autologous blood, is being used to deliver growth factors in high concentration to sites requiring wound healing.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 52, women only. Healthy volunteers may be eligible.
You may be able to join if
- Women undergoing elective cesarean delivery
- Term pregnancy (≥37 weeks of gestation)
You likely can't join if
- Thrombocytopenia (CBC Platelet count \<70,000)
- Connective tissue disease
- Uterine scars other than cesarean (s/p myomectomy, s/p cornual resection)
- Malformed uterus (unicornuate, bicornuate, didelphic)
The study team makes the final eligibility decision.
Where it's taking place
- Ramat Gan, Center, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 52 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ramat Gan, Center, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.